Impact of Lifestyle Modification on the Development of Dementia, Chronic Kidney Disease, Diabetes, Chronic Obstructive Pulmonary Disease, Cancers and Cardiovascular Disease in a Thai General Population

NCT02967406 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3600

Last updated 2017-05-31

No results posted yet for this study

Summary

This is a community-based cluster randomized control trial aimed to investigate the impact of lifestyle modification (diet, physical activity, alcohol drinking and smoking) on the development of dementia, diabetes, chronic kidney disease, cancers, chronic obstructive pulmonary disease and cardiovascular disease in an intermediate risk population in mixed urban-rural areas of Ubon Ratchathani.

Conditions

Interventions

BEHAVIORAL

4 x 4 lifestyle modification

Participants in the intervention group will be given 4x4 lifestyle modification intervention, which will address four health behaviors (diet, physical activity, alcohol drinking and smoking) at four different levels: individual, household, knowledge management and community levels. A new computer program called 'iActive' adapted from the GPAQ with add-on functions to allow real-time assessment and presentation of the energy expenditure along with recommendations specific to each individual will be used. Dietary counseling will be given individually following assessment using a new dietary assessment program called Dietary Assessment Scanning Calculator. Home visit will be done every 3 months by responsible nurses and village health volunteers. Knowledge management will be done through meetings between participants and villages with support from trained nurses. Situation analysis and community action will be encouraged to address four health behaviors.

Sponsors & Collaborators

  • Dementia Association of Thailand

    collaborator UNKNOWN
  • Diabetes Association of Thailand

    collaborator UNKNOWN
  • The Endocrine Society of Thailand

    collaborator OTHER
  • Nephrology Society of Thailand

    collaborator UNKNOWN
  • Thai Dietetic Society

    collaborator UNKNOWN
  • Ubon Ratchathani Public Health Office, Thailand

    collaborator OTHER_GOV
  • Sanpasitthiprasong Hospital

    lead OTHER_GOV

Principal Investigators

  • Prasert Boongird, MD · Dementia Association of Dementia

  • Parinya Chamnan, MD, PhD · Sanpasitthiprasong Hospital

  • Wannee Nitiyanant, MD · Siriraj Hospital

  • Wichai Aekplakorn, MD, PhD · Ramathibodi Hospital, Mahidol University

  • Chanida Pachotikarn, PhD · Thai Dietetic Society

  • Chaicharn Deerochanawong, MD · Rajvithi Hospital

  • Surasak Kantachuvesiri, MD, PhD · Ramathibodi Hospital, Mahidol University

  • Wallaya Jongjaroenprasert, MD · Ramathibodi Hospital, Mahidol University

  • Atiporn Ingsathit, MD, PhD · Ramathibodi Hospital, Mahidol University

  • Win Techakehakij, MD, PhD · Lampang Hospital

  • Phanida Krittayapoositpot, MD · Dementia Association of Thailand

  • Worawan Chailimpamontri, MD · Bhumibol Adulyadej Hospital

  • Ampika Mangklabruks, MD · Faculty of Medicine, Chiangmai University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2027-03-31
Completion
2027-08-31

Countries

  • Thailand

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02967406 on ClinicalTrials.gov